Cargando…
1564. Target Attainment of Empiric Vancomycin Therapy to Achieve Safe and Effective Exposure When it Matters Most: How Much of the Drug Do We Really Need in the First 48 Hours?
BACKGROUND: Empiric dosing of vancomycin (VAN) to reach targets is a daunting task due to the large variability observed in the pharmacokinetics of this agent. With the change to AUC driven dosing on the horizon, the goal of this study was to establish empiric dosing requirements of vancomycin that...
Autores principales: | Yassin, Arsheena, Chin, Titania, Meleshkina, Daria, Ghanbar, Mohammad, Sassine, Joseph, Olivo Freites, Christian, Stavropoulos, Christine, Farkas, Andras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809318/ http://dx.doi.org/10.1093/ofid/ofz360.1428 |
Ejemplares similares
-
1545. Development of a Linear Mixed-Effect Pharmacodynamic Model to Quantify the Effects of Frequently Prescribed Antimicrobials on QT Interval Prolongation in Hospitalized Patients
por: Farkas, Andras, et al.
Publicado: (2019) -
Sorting Out the Risks and Benefits of the #797 Recommended Intrapartum Vancomycin Dosing Approach
por: Farkas, Andras, et al.
Publicado: (2022) -
1820. Indirect Standardization: A Convenient Benchmarking Approach to Antibiotic Utilization Based on Patient Mix
por: Farkas, Andras, et al.
Publicado: (2018) -
1322. Quantifying the Effects of Frequently Prescribed Antimicrobials with Perceived Potential for QT Interval Prolongation during the COVID-19 Era
por: Sy, Hendrik, et al.
Publicado: (2020) -
1300. ACOG Committee Opinion #797 and the Dose of Intrapartum Vancomycin: a Potential Danger to Mother and Newborn Alike
por: Farkas, Andras, et al.
Publicado: (2020)